GeneDx Holdings Corp. Reports Results for Quarter Ended June 30, 2026

What Happened
On August 3, 2026, GeneDx Holdings Corp. filed a Form 8-K announcing it issued a press release and will hold a conference call to report its financial results for the quarter ended June 30, 2026. The company furnished the press release and an earnings presentation as Exhibits 99.1 and 99.2 to the 8-K. The report was signed by CEO Katherine Stueland.

Key Details

• Filing date: August 3, 2026 (Form 8-K, Item 2.02 and Item 9.01 exhibits).
• Event: Press release and conference call announcing quarterly financial results for period ended June 30, 2026.
• Exhibits: 99.1 — Press Release dated August 3, 2026; 99.2 — Earnings Presentation dated August 3, 2026.
• Signed by: Katherine Stueland, Chief Executive Officer.

Why It Matters
This 8-K signals GeneDx will disclose its latest quarterly earnings, revenue and other operating metrics—information investors use to assess near-term performance and guidance. Retail investors should review the press release and earnings presentation (Exhibits 99.1 and 99.2) and consider listening to the company’s conference call for management commentary on revenue, profitability, and outlook.